Reply to the Letter to the Editor Titled “The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?” by Han et al

Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts ACG, Leufkens HGM, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. 2004;90(8):859–65.

CAS  Article  Google Scholar 

Pujades-Rodriguez M, Morgan AW, Cubbon RM and Wu JH. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. Plos Medicine. 2020;17(12).

De P, Roy SG, Kar D, Bandyopadhyay A. Excess of glucocorticoid induces myocardial remodeling and alteration of calcium signaling in cardiomyocytes. J Endocrinol. 2011;209(1):105–14.

CAS  Article  Google Scholar 

Dong R, Zhang M, Hu Q, et al. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int J Mol Med. 2018;41(2):599–614.

CAS  PubMed  Google Scholar 

Yang F, Zhang F, Ji X, et al. Secretory galectin-3 induced by glucocorticoid stress triggers stemness exhaustion of hepatic progenitor cells. J Biol Chem. 2020;295(49):16852–62.

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif